Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by NARJES SAHEB SHARIF-ASKARI
Patients With hMLH1 or/and hMSH2-deficient Metastatic Colorectal Cancer Are Associated With Reduced Levels of Vascular Endothelial Growth Factor-1 Expression and Higher Response Rate to Irinotecan-Based Regimen
Anticancer Research
Medicine
Cancer Research
Oncology
Related publications
Vascular Endothelial Growth Factor Polymorphisms and Clinical Outcome in Colorectal Cancer Patients Treated With Irinotecan-Based Chemotherapy and Bevacizumab
Pharmacogenomics Journal
Molecular Medicine
Genetics
Pharmacology
Serum Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor-1 Levels in Patients With Fibromyalgia Syndrome
Archives of Rheumatology
Rheumatology
Vascular Endothelial Growth Factor Plus Epidermal Growth Factor Receptor Dual Targeted Therapy in Metastatic Colorectal Cancer: Synergy or Antagonism?
Journal of Oncology
Oncology
Preoperative Vascular Endothelial Growth Factor Levels as a Prognostic Marker for Stage II or III Colorectal Cancer Patients
Cancer Growth and Metastasis
Decreased Placental miR-126 Expression and Vascular Endothelial Growth Factor Levels in Patients With Pre-Eclampsia
Journal of International Medical Research
Biochemistry
Medicine
Cell Biology
Capecitabine and Irinotecan as First- Line Chemotherapy for Patients With Metastatic Colorectal Cancer
Journal of IMAB - Annual Proceeding (Scientific Papers)
Dentistry
Serum Levels of Vascular Endothelial Growth Factor and Transforming Growth Factor-.Beta.1 in Patients With Atrial Fibrillation Undergoing Defibrillation Therapy.
Japanese Heart Journal
Thymidine Phosphorylase Expression Is Associated With Time to Progression in Patients With Metastatic Colorectal Cancer
BMC Clinical Pathology
Forensic Medicine
Pathology
Histology
Comparison of EORTC Criteria and PERCIST for PET/CT Response Evaluation of Patients With Metastatic Colorectal Cancer Treated With Irinotecan and Cetuximab
Journal of Nuclear Medicine
Medicine
Nuclear Medicine
Radiology
Imaging
